An albumin-angiotensin converting enzyme 2-based SARS-CoV-2 decoy with FcRn-driven half-life extension.

Authors:
Fuchs E; Rudnik-Jansen I; Dinesen A; Selnihhin D; Mandrup OA and 4 more

Journal:
Acta Biomater

Publication Year: 2022

DOI:
10.1016/j.actbio.2022.09.048

PMCID:
PMC9508356

PMID:
36162760

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Acta Biomater

Abbreviation: Acta Biomater

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Biomedical Engineering

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Flexible IrO<sub>x</sub> neural electrode for mouse vagus nerve stimulation.
Sun T; Tsaava T; Peragine J and 8 more (2023) - Transparency Score: 3/6
The cell-assembled extracellular matrix: A focus on the storage stability and terminal sterilizatio…
Potart D; Gluais M; Gaubert A and 6 more (2023) - Transparency Score: 3/6
ROS-responsive polymer nanoparticles with enhanced loading of dexamethasone effectively modulate th…
Muhammad W; Zhu J; Zhai Z and 10 more (2022) - Transparency Score: 3/6
Single-injection COVID-19 subunit vaccine elicits potent immune responses.
Zhou X; Wang H; Luo Y and 3 more (2022) - Transparency Score: 3/6
Tropocollagen springs allow collagen fibrils to stretch elastically.
Bell JS; Hayes S; Whitford C and 6 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Evidence found in paper:

"This work was supported by the 10.13039/501100011747Novo Nordisk Foundation, CEMBID (Center for Multifunctional Biomolecular Drug Design), Grant Number: NNF17OC0028070). DS work was supported by the Carlsberg Foundation (grant number CF20-0045)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025